| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.92▲ | 3.94▼ | 3.96▼ | 3.94▼ | 3.75▲ |
| MA10 | 3.91▲ | 3.97▼ | 3.96▼ | 3.94▼ | 3.64▲ |
| MA20 | 3.92▲ | 3.96▼ | 3.92▲ | 3.84▲ | 3.17▲ |
| MA50 | 3.97▼ | 3.93▼ | 3.93▼ | 3.59▲ | 3.46▲ |
| MA100 | 3.97▼ | 3.93▼ | 3.94▼ | 3.20▲ | 3.86▲ |
| MA200 | 3.92▲ | 3.93▼ | 3.72▲ | 3.53▲ | 3.79▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | -0.010▼ | 0.003▲ | -0.013▼ | 0.113▲ |
| RSI | 46.154▼ | 46.676▼ | 48.687▼ | 57.875▲ | 58.599▲ |
| STOCH | 81.250▲ | 26.137 | 50.670 | 30.339 | 64.696 |
| WILL %R | -10.000▲ | -77.500▼ | -60.784 | -77.500▼ | -32.461 |
| CCI | 98.246 | -115.600▼ | -11.135 | 5.139 | 105.718▲ |
|
Thursday, August 14, 2025 06:49 PM
GAAP EPS was $(1.00) for Q2 2025, missing analyst expectations by $0.32, or 46.9%. GAAP net income turned positive to $4.2 million in Q2 2025, driven by a $12.8 million non-operating gain. Cash ...
|
|
Thursday, August 14, 2025 01:20 PM
Tvardi Therapeutics, Inc. ("Tvardi") (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat ...
|
|
Thursday, August 14, 2025 05:13 AM
Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company") is pleased to announce that, further to its news release of August 1, 2025, it has received final acceptance from the TSX ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 3.97 | 4.08 | 3.88 | 3.92 | 2,562,800 |
| 14/08/25 | 3.91 | 3.97 | 3.82 | 3.96 | 1,173,991 |
| 13/08/25 | 3.97 | 3.97 | 3.84 | 3.92 | 1,425,200 |
| 12/08/25 | 3.94 | 4.065 | 3.915 | 3.97 | 2,237,795 |
| 11/08/25 | 3.95 | 4.04 | 3.87 | 3.92 | 1,380,200 |
| 08/08/25 | 3.94 | 4.01 | 3.86 | 3.92 | 1,751,300 |
| 07/08/25 | 3.96 | 4.04 | 3.8601 | 3.89 | 2,355,800 |
| 06/08/25 | 4.01 | 4.06 | 3.87 | 3.90 | 1,941,000 |
| 05/08/25 | 3.99 | 4.13 | 3.95 | 4.00 | 2,020,200 |
| 04/08/25 | 3.86 | 3.99 | 3.83 | 3.98 | 1,039,300 |
|
|
||||
|
|
||||
|
|